Search News Archives
Follow us on
Conferences | Events
Media Partners
Sigma-Aldrich

Sigma-Aldrich

Sigma-Aldrich

Products

Contact Sigma-Aldrich


If you have not logged into the website then please enter your details below.

All articles from Sigma-Aldrich

  Baseclick Products now Available through Sigma-Aldrich

Baseclick products are now available through the Sigma-Aldrich catalog.

baseclickCustomers all over the world can now purchase baseclick ́s superior EdU cell proliferation kits via the Sigma-Aldrich website. About the products: The direct detection of cell proliferation is of utmost importance for the monitoring of cell vitality, determining genotoxicity or evaluating anticancer drugs. The baseclick EdU (5-ethynyl-2’-deoxyuridine) cell proliferation assays provide a superior alternative to bromodeoxyuridine (BrdU) assays...

 

  BioSilta and Sigma-Aldrich Sign Global Distribution Agreement

EnPresso growth systems now available to research scientists through Sigma-Aldrich

biosiltaBioSilta Ltd, a developer of advanced, reagent-based microbial growth systems, today announced the signing of a non-exclusive worldwide distribution agreement with Sigma-Aldrich® (Nasdaq: SIAL). Research scientists now have the option of ordering BioSilta’s EnPresso® growth systems for microbial cell cultures through global supplier Sigma-Aldrich. BioSilta’s lead product range, EnPresso B growth systems, offer a series of reagent-based...

 

  Pittcon 2014 Announces Expo Facts

Pittcon 2014 Announces Exposition Highlights

Pittcon 2014 LogoThis year’s exposition welcomes 114 first-time exhibiting companies. The Pittcon 2014 Exposition, which takes place March 3-6 at McCormick Place, Chicago, Illinois, will include 926 exhibitors (count as of February 10, 2014) displaying products and services used by the scientific community in industrial, academic, and government labs. The Exposition will offer the latest innovations in areas such as, but not limited to, analytical chemistry; drug discovery; nanotechnology; life sciences to include forensics, genomics, proteomics, metabolomics; food analysis and safety; environmental science; energy and fuel; and air, water and wastewater analysis...

 

  Sigma Life Science and King's College London co-developing miRNA Target Identification Technology Sigma-AldrichSigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq:SIAL), and King's College London, today announced an exclusive license to develop and commercialize new technology for the identification and validation of microRNA (miRNA) targets in research and clinical diagnostics...

 

  Sigma Life Science and Kraig Biocraft Laboratories to Develop Silkworms for the Production of Spider Silk Sigma-AldrichSigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq:SIAL), today announced the signing of an agreement with Kraig Biocraft Laboratories, Inc. (KBLB) to develop genetically modified silkworms for the production of spider silk, using Sigma's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology. The transfer of silk genes from the spider to the silkworm is expected to allow the mass production of silk with enhanced strength and elasticity with potential textiles and biomedical applications, such as sutures, tendon and ligament repair, bulletproof vests...

 

  Sigma Life Science Launches Suite of Knockout Rats to Model Parkinson’s Disease Sigma-AldrichSigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq:SIAL), announced that its SAGE Labs initiative has created a suite of knockout rat models of Parkinson's disease in collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF). Developed using the proprietary SAGEspeedTM model creation process, these off-the-shelf rat models represent a breakthrough in Parkinson's disease research, overcoming the inherent limitations of the existing mouse models...

 

  Sigma Life Science and SwitchGear Genomics launch a human genome-wide MISSION 3' UTR Lenti GoClone library to identify and validate targets for microRNA regulation Sigma-Aldrich Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich Corporation (Nasdaq:SIAL), today announced the availability of over 10,000 MISSION 3' UTR Lenti GoClones, powered by SwitchGear Genomics Inc., for straightforward microRNA (miRNA) target validation. This novel target reporter system combines SwitchGear Genomics' reporter assay expertise with Sigma Life Science's patented lentiviral technology to provide ready-to-use vectors that can enable scientists to understand gene regulation in a variety of cell types, including primary cells.

 

  Sigma Life Science adds 1,400 Cell Lines to its U.S. Portfolio of ECACC Products Sigma-AldrichSigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (NASDAQ:SIAL), has announced the addition of 1,400 new European Collection of Cell Culture (ECACC) cell lines to its collection of cell line cultures and services. These cell lines have been fully authenticated and tested free of mycoplasma and can now be delivered within days to customers in the U.S., Mexico and Canada. ECACC is a recognized worldwide expert in the maintenance, cultivation and distribution of authenticated cell lines...

 

  Sigma Life Science Launches Pre-designed CompoZr Knockout Zinc Finger Nucleases for Entire Human Genome Sigma® Life Science Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq:SIAL), today announced the release of its pre-designed CompoZr Knockout Zinc Finger Nucleases (ZFNs) technology to knockout any gene in the human genome. The new offer, attractively priced to fit within the budget of a typical laboratory, can generate permanent and heritable gene knockouts in human cell lines within weeks...

 

  Sigma Life Science adds Oligoarchitect for qPCR to Online Portfolio of Scientific Tools Sigma-AldrichSigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq: SIAL), today announced the release of OligoArchitectTM, an online primer and probe design tool. This freely available tool offers automated design of probes and primers for real-time qPCR assays, powered by the industry standard Beacon DesignerTM platform from PREMIER Biosoft, it complements Sigma Life Science's comprehensive portfolio of oligonucleotide and qPCR products and customized oligonucleotide services...

 

  Sigma Life Science Collaborates with Cofactor Genomics to Develop Publically Available Rat Genome Database Sigma-AldrichSigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq: SIAL), today announced that its SAGE Labs initiative has partnered with Cofactor Genomics in an effort to sequence genomes for six of the most widely used strains of rat. As part of the agreement, Cofactor Genomics plans to generate and analyze sequence data using next generation sequencing systems, while SAGE Labs plans to provide the samples and to host a new, free public database at sageresearchmodels.com in late 2011. The database will include exclusive genomic information and analysis tools.

 

  Sigma Life Science Creates World’s First Knock-in Rats using Zinc Finger Nuclease Technology Sigma-AldrichSigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq:SIAL), today announced that its SAGE Labs initiative has successfully used its proprietary CompoZr® Zinc Finger Nuclease (ZFN) technology to generate knock-in rats in which foreign genes have been inserted, or ‘knocked-in', into the rat genome in a precisely targeted manner. This breakthrough achievement represents a major step forward in the creation of a transgenic animal, which may serve as more predictive models of human disease.

 

  Sigma Life Science Awarded Silver in Top Ten Innovations 2010 Sigma Life ScienceSigma Life Science, the innovative biological products and research services business of Sigma-Aldrich® Corporation (Nasdaq:SIAL), today announced that its genetically modified reporter cell lines - based on the CompoZr zinc finger nuclease (ZFN) technology - has taken the silver medal position in The Scientist magazine's Top Ten Innovations for 2010.

 

  Sigma Life Science collection of Prestige Antibodies exceeds 10,000 Sigma Life Science announces the addition of 1,700 new Prestige Antibodies powered by Atlas AntibodiesSigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq:SIAL), today announced the introduction of 1,700 new products to its collection of highly characterized Prestige Antibodies. The entire portfolio - now standing at over 10,000 antibodies and covering 8,400 protein targets - is available online as part of an exclusive partnership with Atlas Antibodies AB.

 

  Domainex Collaborates with Sigma-Aldrich to Advance the Study of Epigenetic Proteins Involved in Cancer and Stem Cell Biology domainexDomainex Ltd the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich (Nasdaq: SIAL) that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research.

 

  Sigma Life Science collaborates with The Jackson Laboratory for distribution of genetically engineered mice sigma life sciencesSigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq:SIAL), and The Jackson Laboratory (JAX), a not-for-profit genetics research institution and the world's premier repository for genetically engineered mice, today announced a joint agreement allowing JAX to distribute mouse models created using Sigma Life Science's proprietary zinc finger nuclease (ZFN) technology.

 

  Sigma Life Science Partners with Autism Speaks to Develop Improved Animal Models of Autism Sigma Advanced Genetic Engineering (SAGE™) Labs to use Proprietary Technologies to Create Genetically Engineered Rat Models to Better Understand Autism and Identify New Therapeutic Approaches

 

  Sigma Life Science to Supply Oligonucleotides to Research Councils UK Sigma® Life Science, a division of Sigma-Aldrich® Corporation and a leading European manufacturer of oligonucleotides, has signed a three-year contract with Research Councils UK (RCUK) Shared Services Centre Limited to be a prefered supplier for synthetic oligonucleotides.

 

  Sigma Life Science launches range of engineered cell lines exploiting CompoZr zinc finger nuclease technology Sigma Life Science, the innovative biological products and research services business of Sigma-Aldrich® Corporation (Nasdaq:SIAL), today announced the global release of a pioneering range of engineered mammalian cell lines. This new product range combines Sigma's proprietary CompoZr zinc finger nuclease (ZFN) technology with the Company's extensive experience in gene silencing, to offer innovative tools for drug discovery, compound screening and fundamental research applications.

 

  SAFC and Novozymes Biopharma extend joint agreement for the exclusive distribution of LONGR3 growth factor SAFC®, a member of the Sigma-Aldrich® Group (NASDAQ: SIAL), and Novozymes Biopharma DK A/S today announced a 10-year extension of their joint agreement under which SAFC retains exclusive marketing and distribution rights for Novozymes Biopharma's LONG®R³IGF-I (LONG®R3) growth factor used for industrial cell culture applications.

 

 

Media Partners